Lv4
580 积分 2023-04-25 加入
Novel antibody-drug conjugate based on DXd-ADC technology
29天前
已完结
Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003
1个月前
已关闭
Radiotherapy activates picolinium prodrugs in tumours
1个月前
已完结
Molecular glues targeting GSPT1 in cancers: A potent therapy
2个月前
已完结
Claudin 18.2 as a novel therapeutic target
2个月前
已完结
Current developments in gastric cancer: from molecular profiling to treatment strategy
3个月前
已完结
Modulation of STIM1 by a risk insertion/deletion polymorphism underlying genetics susceptibility to sudden cardiac death originated from coronary artery disease
4个月前
已完结
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
4个月前
已完结
MHC class III lymphocyte antigens 6 as endogenous immunotoxins: Unlocking immunotherapy in proficient mismatch repair colorectal cancer
6个月前
已完结
Toxicities From Antibody-Drug Conjugates
6个月前
已完结
皖公网安备34019202002308
